Hepatic Impairment Study

Completed · Phase 1

Conditions studied: Liver Disease

In brief

This study is to find out how the subject's body processes and reacts to the study drug, and to find out how long it remains in the subjects system after one dose. Subjects with varying degrees of liver function are being asked to participate in this study. Study results from subjects with normal liver function will be compared with study results from subjects with impaired liver function.

Key facts

Study ID

NCT00829231

Run by

Bayer

People needed

45

Starts

2009-01-01

Expected to finish

2009-07-01

Last updated by the study team

2014-11-03

Who can join

Age: 50 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy Subjects, Child Pugh A and Child Pugh B Liver Disease Patients.

Where it is running

• Study site — Miami, Florida, United States
• Study site — Orlando, Florida, United States
• Study site — Knoxville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.